drugset / Trial / NCT03177850
Effect of Acetazolamide on Sleep Related Breathing Disturbances in Patients With Respiratory Disease at Altitude
Phase 4
Completed
185 enrolled
University of Zurich
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
In this trial, the investigators will evaluate the effect of acetazolamide (375 mg per day) vs. placebo on sleep related breathing disturbances at altitude in patients with COPD.
Timeline
- Start
- 2017-05-24
- Primary completion
- 2018-08-02
- Completion
- 2018-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetazolamide | Small molecule | 375 mg | Oral |